About Us

The Canadian Cancer Clinical Trials Network (3CTN) is a pan-Canadian initiative to improve recruitment and the efficiency and quality of academic clinical trials in Canada.

Our Backbone: Cancer Centres

The backbone of the 3CTN initiative are the member sites that collaborate and communicate via our innovative Network structure.

Our Voice: Patient Representatives

Patient Representatives can contribute a crucial perspective to clinical trials by providing feedback, insight, expertise and support towards trial activities and initiatives.

Coordinating Centre

At the pinnacle of the Network, The 3CTN Coordinating Centre acts as the leadership and communication hub for the Network and is responsible for supporting and coordinating activities at the Network sites, in order to reach the Network’s goals and objectives.

Janet Dancey, MD
  • Scientific Director
Bernie Eigl, MD
  • Associate Scientific Director
Gerald Batist, MD
  • Associate Scientific Director
Stephen Sundquist
  • Executive Director
Lam Pho
  • Director, Information Technology
Diana Kato
  • Manager, Operations
Saher Lalani
  • Project Financial Analyst
Rebecca Xu
  • Manager, Portfolio and Informatics
James Schoales
  • Portfolio Data Coordinator
Rebecca Rose
  • Clinical Research Project Manager
Saranya Kulendran
  • Project Lead

Our Governance

Each committee in our governance brings expert knowledge at a high level, which is crucial to the success of 3CTN as it provides a link to the broader Canadian cancer research environment with the aim of maintaining 3CTN’s relevance and sustainability.

Scientific Advisory Board

David Cameron, MD
  • Chair, Breast International Group
Gavin Stuart, MD
  • Professor, Division of Gynecologic Oncology, University of British Columbia
Patrick Sullivan
  • Patient Representative
Stephen Sundquist
  • Executive Director, 3CTN
Janet Dancey, MD
  • Scientific Director, 3CTN

Funders Oversight Committee

Craig Earle, MD (Chair)
  • Vice President, Cancer Control Canadian Partnership Against Cancer
Rami Rahal
  • Vice President, Cancer Systems, Performance and Innovation, Canadian Partnership Against Cancer
Ian Tannock, MD
  • Emeritus Professor of Medical Oncology, Princess Margaret Cancer Centre
Megan Lee
  • Vice President, Program Investment (Acting), Alberta Cancer Foundation
Gerald Batist, MD
  • Scientific Director, Q-Clinical Research Organization in Cancer (Q-CROC)
Bernie Eigl, MD
  • Provincial Director, Systemic Therapy Clinical Trials, BC Cancer Agency
Lynette Hillier
  • Executive Director, Eastern Regional Health Authority
Antonia Palmer
  • Patient Representative
Farah McCrate, PhD
  • Director, Research & Innovation, Eastern Regional Health Authority
Kathryn Dyck
  • Manager, Clinical Trials Unit, CancerCare Manitoba
Christine Williams, PhD
  • Deputy Director and Head, Clinical Translation, Ontario Institute for Cancer Research
Teresa Petrocelli, PhD (Alternate)
  • Director, Clinical Translation, Ontario Institute for Cancer Research
Stephen Sundquist
  • Executive Director, 3CTN
Janet Dancey, MD
  • Scientific Director, 3CTN

Management and Executive (*) Committee

Ian Tannock*, MD (Chair)
  • Emeritus Professor of Medical Oncology, Princess Margaret Cancer Centre
Janet Dancey*, MD
  • Scientific Director, 3CTN
Bernie Eigl*, MD
  • Provincial Director, Systemic Therapy Clinical Trials, BC Cancer Agency
Annette Cyr*
  • Patient Representative and Chair, Melanoma Network of Canada
Gerald Batist*, MD
  • Scientific Director, Q-Clinical Research Organization in Cancer (Q-CROC)
Tracie Hanna
  • Manager, Cancer Clinical Research Team, Kingston Health Sciences Centre
Joseph Pater, MSc, MD
  • Emeritus Professor, Queen’s University
Jim Pankovich
  • Vice President, Clinical Operations & Drug Development, Qu Biologics
Arik Drucker, MD
  • Medical Oncologist, Nova Scotia Cancer Centre
Glenn Bauman, MD
  • Radiation Oncology, London Regional Cancer Program
Patricia Tang, MD
  • Clinical Assistant Professor, Department of Oncology, Tom Baker Cancer Centre
Jim Whitlock, MD
  • Division Head, Haematology/Oncology, The Hospital for Sick Children
Joel Gingerich, MD
  • Medical Director, Community Oncology, CancerCare Manitoba
John Thoms, MD
  • Physician Director, Clinical Trials, Dr. H. Bliss Murphy Cancer Centre
Stephen Sundquist
  • Executive Director, 3CTN
Lam Pho
  • Director, Information Technology, 3CTN

Our Operating/Advisory Committees

Portfolio Committee

This team is responsible for reviewing the criteria for trial entry into the Portfolio and metrics for trial retention within the Portfolio; and reviewing the trial Portfolio for scientific merit, priority, performance and strategic balance to cover the range of trials of interest/relevance to Canadians and the Canadian health care system.

Joseph Pater, MSc, MD (Chair)
  • Emeritus Professor, Queen’s University
Stephen Chia, MD
  • Medical Oncologist, BC Cancer Agency, Vancouver Clinic
Lynn Dwernychuk
  • Provincial Leader, Clinical Research, Saskatchewan Cancer Agency
Julie Lemieux, MD
  • Medical Oncologist, CHU de Quebec
Judy Needham
  • Patient Representative, British Columbia
Carol Portwine, MD
  • Associate Professor, Department of Pediatrics, McMaster University
Krista Rideout
  • Manager, Clinical Research, Eastern Health
Jim Wright, MD
  • Radiation Oncologist, Juravinski Cancer Centre
Janet Dancey, MD
  • Scientific Director, 3CTN
Stephen Sundquist
  • Executive Director, 3CTN
Rebecca Xu
  • Portfolio and Informatics Manager, 3CTN
James Schoales
  • Portfolio Data Coordinator, 3CTN

Performance Strategy Team

This team is responsible for evaluating Network performance, identifying problems and proposing new initiatives, tools to improve the efficiency and quality of trial activities, improvements to and competencies of clinical trial staff through education, training and mentoring and greater patient access to trials.

Marie-Chantal Delisle
  • Project Manager, Clinical Research Network, Q-CROC
Lynn Dwernychuk
  • Director, Clinical Research, Saskatchewan Cancer Agency
Kathryn Dyck
  • Clinical Trials Manager, CancerCare Manitoba
Carla Girolametto
  • Clinical Manager, Grand River Hospital
Tracie Hanna
  • Clinical Manager, Kingston Health Sciences Centre
Brenda Kowaleski
  • Clinical Trials Manager, Juravinski Cancer Centre
Dora Nomikos
  • Manager, Trial Management Group, Canadian Cancer Trials Group
Alison Van Nie
  • Research Ethics Officer, Ontario Institute for Cancer Research
Philip Pollock
  • Manager, Clinical Trials & Clinical Research, Vancouver Island Centre, BC Cancer
Debra Walker
  • Patient Representative
Stephen Sundquist
  • Executive Director, 3CTN

Patient Representative Advisory Committee (PRAC)

The PRAC is a team of 3CTN Patient Representatives and 3CTN CC staff with the focus of providing feedback, insight, expertise and support to the Network.

Fred Clark (Chair)
  • Manitoba
Gretta Hutton
  • Ontario
Judy Needham
  • British Columbia
Louis Gagne
  • Quebec
Jean Francois Denault
  • Quebec
Stephanie Mayne
  • Newfoundland
Alison Stoneman
  • Ontario
Stephen Sundquist
  • Executive Director, 3CTN

Our Partners

Our Canada-wide initiative is made possible by contributions from our funders and through collaborations with organizations who share our vision for the cancer clinical trial landscape.

Funding Partners

Collaborators

Partner with Us

Join us in improving the clinical trials landscape for cancer researchers and patients across Canada.